相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The acid sphingomyelinase/ceramide system in COVID-19
Johannes Kornhuber et al.
MOLECULAR PSYCHIATRY (2022)
Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro
Senem Merve Fred et al.
FRONTIERS IN PHARMACOLOGY (2022)
Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study
Nicolas Hoertel et al.
TRANSLATIONAL PSYCHIATRY (2022)
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States
Quan Qiu Wang et al.
MOLECULAR PSYCHIATRY (2021)
Increased risk ofCOVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States
QuanQiu Wang et al.
WORLD PSYCHIATRY (2021)
Dexamethasone use and mortality in hospitalized patients with coronavirus disease 2019: A multicentre retrospective observational study
Nicolas Hoertel et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19
Nicolas Hoertel et al.
CLINICAL DRUG INVESTIGATION (2021)
Impact of the timing and adherence to face mask use on the course of the COVID-19 epidemic in France
Nicolas Hoertel et al.
JOURNAL OF TRAVEL MEDICINE (2021)
Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study
Nicolas Hoertel et al.
MOLECULAR PSYCHIATRY (2021)
Observational study of haloperidol in hospitalized patients with COVID-19
Nicolas Hoertel et al.
PLOS ONE (2021)
A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders
Ahmad A. Toubasi et al.
PSYCHIATRY RESEARCH (2021)
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19
Katlyn Nemani et al.
JAMA PSYCHIATRY (2021)
Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19
David Seftel et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Fluoxetine Can Inhibit SARS-CoV-2 In Vitro
Arthur Dechaumes et al.
MICROORGANISMS (2021)
Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study
Gil Darquennes et al.
PHARMACEUTICALS (2021)
Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients
Crisanto Diez-Quevedo et al.
ACTA PSYCHIATRICA SCANDINAVICA (2021)
Mood Disorders and Outcomes of COVID-19 Hospitalizations
Victor M. Castro et al.
AMERICAN JOURNAL OF PSYCHIATRY (2021)
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Melissa Zimniak et al.
SCIENTIFIC REPORTS (2021)
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
Vikas P. Sukhatme et al.
FRONTIERS IN PHARMACOLOGY (2021)
Hybrid Deep Learning for Medication-Related Information Extraction From Clinical Texts in French: MedExt Algorithm Development Study
Jordan Jouffroy et al.
JMIR MEDICAL INFORMATICS (2021)
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
Justin Fortune Creeden et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter Study
Nicolas Hoertel et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties
Emmanuel Stip et al.
MOLECULAR PSYCHIATRY (2021)
Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms
Nicolas Hoertel et al.
MOLECULAR PSYCHIATRY (2021)
ORIGINAL RESEARCH Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020-March 2021
Lyudmyla Kompaniyets et al.
PREVENTING CHRONIC DISEASE (2021)
FLUOXETINE USE IS ASSOCIATED WITH IMPROVED SURVIVAL OF PATIENTS WITH COVID-19 PNEUMONIA: A RETROSPECTIVE CASE-CONTROL STUDY
Zsofia Klara Nemeth et al.
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE (2021)
Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis
Benedetta Vai et al.
LANCET PSYCHIATRY (2021)
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records
Maxime Taquet et al.
LANCET PSYCHIATRY (2021)
Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells
Alexander Carpinteiro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Francisco Alejandro Lagunas-Rangel
JOURNAL OF MEDICAL VIROLOGY (2020)
Disparities in the Use of General Somatic Care among Individuals Treated for Severe Mental Disorders and the General Population in France
Coralie Gandre et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Prognosis analysis of patients with mental disorders with COVID-19: a single -center retrospective study
Yan Wan et al.
AGING-US (2020)
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
Shruti Gupta et al.
JAMA INTERNAL MEDICINE (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
A stochastic agent-based model of the SARS-CoV-2 epidemic in France
Nicolas Hoertel et al.
NATURE MEDICINE (2020)
COVID-19 outcomes among people with intellectual and developmental disability living in residential group homes in New York State
Scott D. Landes et al.
DISABILITY AND HEALTH JOURNAL (2020)
Association of a Prior Psychiatric Diagnosis With Mortality Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Infection
Luming Li et al.
JAMA NETWORK OPEN (2020)
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
Eric J. Lenze et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells
Alexander Carpinteiro et al.
CELL REPORTS MEDICINE (2020)
Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis
Huazhen Yang et al.
LANCET HEALTHY LONGEVITY (2020)
COVID-19 and people with intellectual disability: impacts of a pandemic
K. Courtenay et al.
IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE (2020)
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine
Sebastian Schloer et al.
EMERGING MICROBES & INFECTIONS (2020)
Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis
Dorian A. Rosen et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
Joseph Firth et al.
LANCET PSYCHIATRY (2019)
Network abnormalities in generalized anxiety pervade beyond the amygdala-pre-frontal cortex circuit: Insights from graph theory
Elena Makovac et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2018)
Mortality in Mental Disorders and Global Disease Burden Implications A Systematic Review and Meta-analysis
Elizabeth Reisinger Walker et al.
JAMA PSYCHIATRY (2015)
CORRELATION IS NO CAUSATION: GYMNASIUM PROLIFERATION AND THE RISK OF OBESITY
Yann Le Strat et al.
ADDICTION (2011)
Increased Acid Sphingomyelinase Activity in Peripheral Blood Cells of Acutely Intoxicated Patients With Alcohol Dependence
Martin Reichel et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)
The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments
Rodrigo Machado-Vieira et al.
PHARMACEUTICALS (2010)
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
Erik von Elm et al.
ANNALS OF INTERNAL MEDICINE (2007)
Anti-inflammatory properties of desipramine and fluoxetine
Caroline Roumestan et al.
RESPIRATORY RESEARCH (2007)